Similar articles

• [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Aug 18;147(33-34):51. MMW Fortschr Med. 2005. PMID: 16138641 German. No abstract available.
• [AVERT [The Atorvastatin versus Revascularization Treatment]].

  Mokuno H. Mokuno H. Nihon Rinsho. 2001 Mar;59 Suppl 3:436-41. Nihon Rinsho. 2001. PMID: 11347110 Review. Japanese. No abstract available.
• [Atorvastatin].

  Kajinami K, Takekoshi N. Kajinami K, et al. Nihon Rinsho. 2001 Mar;59 Suppl 3:598-604. Nihon Rinsho. 2001. PMID: 11347138 Review. Japanese. No abstract available.
• [CARDS confirms usefulness of LDL lowering in type 2 diabetics].

  Bern VH. Bern VH. Praxis (Bern 1994). 2004 Oct 27;93(44):1 p following 1830. Praxis (Bern 1994). 2004. PMID: 15559908 German. No abstract available.
• Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.

  Strandberg TE, Feely J, Sigurdsson EL; DISCOVERY study group. Strandberg TE, et al. Clin Ther. 2004 Nov;26(11):1821-33. doi: 10.1016/j.clinthera.2004.11.015. Clin Ther. 2004. PMID: 15639694 Clinical Trial.